Caption Management, LLC Denali Therapeutics Inc. Put Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$14.96 - $23.22 $448,800 - $696,600	30,000 New	30,000 $696,000
Q3 2023 Nov 14, 2023	BUY	$20.63 - $30.17 $618,900 - $905,100	30,000 New	30,000 $618,000
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $870,000 - $1.42 Million	-30,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$42.59 - $55.02 $1.12 Million - $1.44 Million	-26,200 Reduced 46.62%	30,000 $1.34 Million
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $1.27 Million - $2.05 Million	26,200 Added 87.33%	56,200 $2.84 Million
Q2 2021 Aug 16, 2021	BUY	$50.3 - $78.44 $1.51 Million - $2.35 Million	30,000 New	30,000 $2.35 Million
Q1 2021 May 17, 2021	SELL	$53.8 - $81.53 $2.02 Million - $3.06 Million	-37,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$36.89 - $93.56 $1.38 Million - $3.51 Million	37,500 New	37,500 $3.14 Million

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.